ArticleInternal and emergency medicine2025

Targeting Janus kinase 1 in refractory Behçet's disease: a case report on the clinical efficacy of upadacitinib.

Claudia Ammoscato et al.PubMed ↗Publisher ↗

No numbers read from the abstract.